Biosimilars Council's Craig Burton testifies before Congress on biosimilars crisis
Regulatory obstacles and anticompetitive abuses threaten patient care; American healthc are system on track to lose $189 billion in patient savings.
Pharmacy
Teva and Samsung Bioepis announce Biosimilar EPYSQLI Injection now available in the U.S.
In January 2025, Teva and Samsung Bioepis entered into a strategic partnership for the commercialization of EPYSQLI in the U.S. market.
CVS Health announces chief financial officer transition plan; appoints chief medical officer
Brian Newman has been named executive vice president and chief financial officer designate, effective April 21 and Dr. Amy Compton-Phillips will be the company’s new executive vice president and chief medical officer, effective May 19.
CVS Health offers MinuteClinic health services for women
The initiative came in response to growing demand for care that acknowledges the specific challenges women face — from menopause and maternal mental health to heart health and healthy aging.
Rite Aid considers second bankruptcy filing
Rite Aid filed for Chapter 11 bankruptcy protection in October 2023. It emerged from bankruptcy as a private company.
CARE Pharmacies appoints Wafaa Berrady new CFO
Wafaa Berrady will oversee all aspects of the cooperative’s financial operations, including strategic planning, financial forecasting, and risk management.
Trump administration drops Biden's proposal of Medicare weight-loss drug coverage
The proposal would have enabled more Americans to afford new medications in the GLP-1 class that have been shown to reduce weight by as much as 20% and prevent type 2 diabetes, but cost as much as $1,000 a month without insurance coverage.
The IDF reports over 250 million people worldwide are unaware they have diabetes
New estimates from the IDF Diabetes Atlas highlight the growing diabetes threat, with nearly one in nine adults now living with the condition.
FTC lawsuit against PBMs for insulin pricing back on
Earlier this week, the FTC had put the case on hold due to the recusal of Chairman Andrew Ferguson and fellow Republican Melissa Holyoak. Both had decided to step back from the case due to their past involvement with PBM-related cases.
AAM congratulates Dr. Mehmet Oz on confirmation as CMS administrator
“AAM and the Biosimilars Council look forward to working with Dr. Oz and his team at CMS to ensure lower-cost medicines are always available for America’s patients.”
NACDS congratulates Dr. Mehmet Oz on confirmation as CMS administrator
NACDS calls for swift action on PBM reform legislation and implementation to safeguard Americans’ healthcare affordability and accessibility,
Camber launches Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate Oral Solution is an osmotic laxative indicated for cleansing of the colon in preparation for colonoscopy in adult patients.
GoodRx rolls out new e-commerce experience for retail pharmacies
The company is launching the experience with Midwest-based supermarket chain Hy-Vee.
FTC haults action against PBMs accused of plan that raised insulin prices
The stay in the action is for at least 105 days.
McKesson Corp. completes PRISM Vision Holdings deal
Announces fourth quarter and full year fiscal 2025 earnings release date.